PBSV Pharma-bio Serv, Inc.

Fundamentals / CIK 0001304161 / USD

Pharma-bio Serv, Inc. reported $9.48M in revenue and net income of $252K for the trailing twelve months ended July 31, 2026 (up 19.0% year over year), with a 32.3% gross margin and a -1.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PBSV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$21.47M$10.74M$0-$3.79MFY 2016 Revenue: $19.54MFY 2016 Net Income: -$257K2016FY 2017 Revenue: $13.30MFY 2017 Net Income: -$1.41M2017FY 2018 Revenue: $17.80MFY 2018 Net Income: $1.28M2018FY 2019 Revenue: $19.51MFY 2019 Net Income: $2.09M2019FY 2020 Revenue: $21.56MFY 2020 Net Income: $2.05M2020FY 2021 Revenue: $20.12MFY 2021 Net Income: -$2.09M2021FY 2022 Revenue: $19.40MFY 2022 Net Income: $1.01M2022FY 2023 Revenue: $16.98MFY 2023 Net Income: $1.31M2023FY 2024 Revenue: $9.51MFY 2024 Net Income: -$778K2024FY 2025 Revenue: $9.00MFY 2025 Net Income: -$100K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31
Revenue $9.00M $9.51M $16.98M $19.40M $20.12M $21.56M $19.51M $17.80M $13.30M $19.54M
Cost of Revenue $6.09M $6.99M $11.91M $14.52M $14.76M $14.90M $13.33M $12.11M $9.46M --
Gross Profit $2.91M $2.52M $5.07M $4.88M $5.36M $6.67M $6.18M $5.69M $3.84M $5.78M
Selling, General & Admin $3.55M $3.80M $3.95M $3.71M $9.21M $4.44M $4.48M $4.60M $4.66M $5.87M
Operating Income -$638K -$1.29M $1.12M $1.17M -$3.85M $2.23M $1.70M -$1.26M -$778K -$92K
EBITDA -$578K -$1.26M $1.17M $1.23M -$3.78M $2.31M $1.80M -$1.19M -$670K $221K
Interest Income $38K $246K $320K $0 -- -- -- -- -- --
Income Before Tax -$94K -$755K $1.69M $1.19M -$1.88M $2.29M $2.22M $1.52M -$774K -$204K
Income Tax Expense $6.2K $22K $377K $182K $213K $239K $136K $2.79M $3.9K $53K
Net Income -$100K -$778K $1.31M $1.01M -$2.09M $2.05M $2.09M $1.28M -$1.41M -$257K
Basic EPS -- -- -- -- -- $0.09 $0.09 -- -$0.06 -$0.01
Diluted EPS -$0.00 -$0.03 $0.06 -- -- $0.09 $0.09 -- -$0.06 -$0.01
Basic Shares Outstanding 22.9M 23.0M 23.0M 23.0M 23.0M 23.0M 23.1M 23.1M 23.1M 23.0M
Diluted Shares Outstanding 23.0M 23.0M 23.0M 23.0M 23.2M 23.0M 23.1M 23.1M 23.1M 23.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Revenue $2.34M $2.70M $2.29M $2.15M $1.96M $2.42M $2.47M $2.33M
Cost of Revenue $1.64M $1.80M $1.57M $1.40M $1.39M $1.60M $1.70M $1.61M
Gross Profit $692K $902K $722K $749K $574K $819K $768K $727K
Selling, General & Admin $764K $757K $817K $882K $888K $917K $860K $881K
Operating Income -$72K $145K -$95K -$133K -$314K -$98K -$92K -$154K
EBITDA -$58K $158K -$80K -$117K -$298K -$79K -$83K -$148K
Interest Income -- -- $83K -- -- -- $138K -$35K
Income Before Tax -$11K $239K $36K $4.3K -$209K $101K $9.7K -$15K
Income Tax Expense $3.1K $6.4K $3.6K $4.4K -$4.8K $5.5K $1.1K -$31K
Net Income -$14K $233K $33K -$102 -$204K $95K $8.5K $16K
Diluted EPS -$0.00 $0.01 $0.00 -- -$0.01 $0.00 $0.00 --
Basic Shares Outstanding 22.9M 22.9M 22.9M -- 22.9M 22.9M 23.0M --
Diluted Shares Outstanding 22.9M 22.9M 22.9M -- 22.9M 22.9M 23.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31
Cash & Cash Equivalents -- -- -- $14.46M $17.47M $17.14M $15.49M $16.03M $11.59M $13.77M
Short-Term Investments $7.48M $5.98M $4.53M $0 -- -- $0 $44K $27K $20K
Cash & Short-Term Investments -- -- -- $14.46M $17.47M $17.14M $15.49M $16.07M $11.62M $13.79M
Accounts Receivable, Net $2.36M $2.51M $3.94M $4.98M $4.61M $9.73M $8.78M $5.19M $6.32M $6.85M
Other Current Assets -- -- -- -- -- $469K $454K $394K $443K $981K
Total Current Assets $13.39M $15.70M $19.40M $19.94M $22.82M $28.58M $25.97M $23.41M $21.68M $21.63M
Property, Plant & Equipment, Net $116K $169K $33K $74K $106K $218K $291K $298K $251K $2.33M
Other Non-Current Assets $121K $226K $112K $131K $353K $270K $367K $418K $423K $36K
Total Non-Current Assets $266K $593K $501K $707K $1.10M $1.33M $658K $1.97M $674K $2.37M
Total Assets $13.65M $16.29M $19.90M $20.65M $23.92M $29.92M $26.63M $25.38M $22.35M $24.00M
Accounts Payable -- -- -- $1.63M $2.07M -- -- -- -- --
Total Current Liabilities $1.74M $1.89M $2.15M $2.11M $2.67M $3.79M $3.67M $2.57M $1.54M $2.16M
Other Non-Current Liabilities -- -- -- -- -- -- $18K $18K $0 --
Total Non-Current Liabilities $0 $690K $1.62M $1.99M $2.34M $3.41M $2.36M $2.55M $60K $29K
Total Liabilities $1.74M $2.58M $3.78M $4.09M $5.01M $7.20M $6.03M $5.11M $1.60M $2.19M
Total Debt (incl. Leases) $29K $194K $347K $487K $617K $860K $78K -- -- --
Common Stock $2.4K $2.4K $2.4K $2.3K $2.3K $2.3K $2.3K $2.3K $2.3K $2.3K
Retained Earnings $10.53M $12.35M $14.85M $15.27M $17.71M $21.52M $19.47M $19.11M $19.56M $20.98M
Accumulated Other Comp. Income $278K $262K $210K $238K $144K $161K $144K $108K $138K -$166K
Total Stockholders' Equity $11.91M $13.72M $16.13M $16.56M $18.91M $22.72M $20.61M $20.26M $20.75M $21.81M
Total Equity $11.91M $13.72M $16.13M $16.56M $18.91M $22.72M $20.61M $20.26M $20.75M $21.81M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Short-Term Investments $7.06M $6.68M $4.80M $7.48M $6.77M $8.31M $5.13M $5.98M
Accounts Receivable, Net $2.42M $2.72M $2.65M $2.36M $2.02M $2.68M $2.68M $2.51M
Total Current Assets $11.24M $11.29M $13.32M $13.39M $13.16M $13.42M $15.53M $15.70M
Property, Plant & Equipment, Net $80K $92K $104K $116K $132K $145K $160K $169K
Other Non-Current Assets $121K $121K $121K $121K $226K $226K $226K $226K
Total Non-Current Assets $201K $213K $224K $266K $430K $486K $543K $593K
Total Assets $11.44M $11.50M $13.55M $13.65M $13.59M $13.90M $16.08M $16.29M
Total Current Liabilities $995K $1.05M $3.31M $1.74M $1.66M $1.78M $3.42M $1.89M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $661K $690K
Total Liabilities $995K $1.05M $3.31M $1.74M $1.66M $1.78M $4.08M $2.58M
Total Debt (incl. Leases) -- -- -- $29K $71K $113K $154K $194K
Common Stock $2.4K $2.4K $2.4K $2.4K $2.4K $2.4K $2.4K $2.4K
Retained Earnings $9.07M $9.08M $8.85M $10.53M $10.53M $10.74M $10.64M $12.35M
Accumulated Other Comp. Income $251K $255K $280K $278K $286K $283K $244K $262K
Total Stockholders' Equity $10.44M $10.45M $10.24M $11.91M $11.93M $12.12M $12.00M $13.72M
Total Equity $10.44M $10.45M $10.24M $11.91M $11.93M $12.12M $12.00M $13.72M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31
Net Income -$100K $778K -$1.31M $1.01M -$2.09M $2.05M $2.09M $1.28M -$1.41M -$257K
Depreciation & Amortization $60K $23K $48K $51K $73K $86K $99K $75K $108K $313K
Stock-Based Compensation $35K $48K $45K $72K $56K $43K $34K $52K $64K $89K
Change in Receivables $204K $1.46M $1.09M $463K -$135K $944K -$3.59M $1.16M $140K $647K
Operating Cash Flow -$215K -$567K $1.89M $592K $805K $1.51M -$2.21M $3.72M -$923K $710K
Capital Expenditure -$6.6K -$160K -$7.3K -$19K -$11K -$56K -$57K -$122K -$57K -$1.81M
Free Cash Flow -$222K -$726K $1.88M $573K $794K $1.46M -$2.27M $3.60M -$980K -$1.10M
Purchases of Investments -- -- -$4.21M $0 -- -- -- -- -- --
Investing Cash Flow -$1.47M -$1.36M -$4.22M -$19K $1.30M -$29K $1.84M -$116K -$9.2K -$1.78M
Share Repurchases -$31K -$11K -$34K -$82K -$26K -$1.7K -$88K -$57K -$15K -$46K
Dividends Paid -$1.72M -$1.72M -$1.72M -$3.45M -$1.73M -$1.73M $0 -- -- --
Financing Cash Flow -$1.75M -$1.73M -$1.76M -$3.53M -$1.75M $205K -$156K -$1.80M -$71K -$69K
Net Change in Cash -$3.39M -$3.68M -$4.02M -$3.01M $330K $1.65M -$540K $4.44M -$2.18M -$1.12M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Net Income -$14K $233K $33K -$102 -$204K $95K $8.5K $1.57M
Depreciation & Amortization $14K $14K $15K $16K $16K $19K $9.4K $5.9K
Stock-Based Compensation $8.6K $8.6K $8.6K $4.4K $10.0K $10K $11K $3.1K
Change in Receivables $296K -$78K -$277K -$348K $675K $62K -$186K $89K
Operating Cash Flow $61K -$365K -$390K $280K $237K -$302K -$429K $78K
Capital Expenditure -$1.4K -$2.3K -$2.4K -$350 -$2.0K -$4.3K $0 -$157K
Free Cash Flow $60K -$368K -$393K $279K $234K -$306K -$429K -$79K
Investing Cash Flow -$326K -$1.89M $2.77M -$857K $1.63M -$3.23M $988K $172K
Share Repurchases $0 -$709 -$1.7K -$9.2K -$5.0K -$17K $0 $0
Dividends Paid $0 -$1.72M -- -- $0 -$1.72M -- $0
Financing Cash Flow $0 -$1.72M -$1.7K -$9.2K -$5.0K -$1.74M $0 $0
Net Change in Cash -$273K -$3.97M $2.38M -$579K $1.86M -$5.21M $540K $247K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31 Oct 31
Gross Margin 32.3% 26.5% 29.8% 25.2% 26.6% 30.9% 31.7% 32.0% 28.9% 29.6%
Operating Margin -7.1% -13.5% 6.6% 6.1% -19.2% 10.3% 8.7% -7.1% -5.8% -0.5%
Net Profit Margin -1.1% -8.2% 7.7% 5.2% -10.4% 9.5% 10.7% 7.2% -10.6% -1.3%
Return on Equity (ROE) -0.8% -5.7% 8.1% 6.1% -11.0% 9.0% 10.1% 6.3% -6.8% -1.2%
Return on Assets (ROA) -0.7% -4.8% 6.6% 4.9% -8.7% 6.9% 7.8% 5.0% -6.3% -1.1%
Current Ratio 7.70x 8.32x 9.01x 9.46x 8.55x 7.54x 7.08x 9.13x 14.05x 10.02x
Quick Ratio -- -- -- 9.23x 8.27x 7.08x 6.61x 8.29x 11.62x 9.57x
Debt to Equity 0.00x 0.01x 0.02x 0.03x 0.03x 0.04x 0.00x -- -- --
Revenue Growth (YoY) -5.3% -44.0% -12.5% -3.6% -6.7% +10.5% +9.6% +33.8% -31.9% -16.5%
Gross Profit Growth (YoY) +15.7% -50.3% +3.8% -8.9% -19.6% +7.9% +8.6% +48.0% -33.6% -22.7%
Operating Income Growth (YoY) -- -215.2% -4.9% -- -273.2% +31.2% -- -- -- -105.2%
Net Income Growth (YoY) -- -159.4% +30.1% -- -201.9% -1.7% +63.1% -- -- -115.8%
EPS Growth (YoY) -- -- -- -- -- -1.1% -- -- -- -115.7%
Operating Cash Flow Growth (YoY) -- -130.0% +219.2% -26.4% -46.9% -- -159.4% -- -230.0% +90.5%
Free Cash Flow Growth (YoY) -- -138.6% +228.6% -27.8% -45.6% -- -163.0% -- -- -3733.8%
5Y Revenue / Share Growth -58.2% -51.1% -4.2% +46.5% +2.9% -7.5% -29.4% -48.2% -59.1% -11.6%
10Y Revenue / Share Growth -61.3% -65.5% -50.4% -40.1% -9.0% +71.4% -- -- -- --
5Y Net Income / Share Growth -104.9% -137.4% +2.9% -- -- +26.6% -13.8% -74.9% -127.1% -107.3%
10Y Net Income / Share Growth -106.2% -132.2% -74.2% -80.6% -159.6% +397.5% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Gross Margin 32.3% 32.4% 32.5% 32.3% 31.4% 30.6% 28.6% 26.5%
Operating Margin -1.6% -4.4% -7.3% -7.1% -7.2% -7.5% -9.8% -13.5%
Net Profit Margin 2.7% 0.7% -0.9% -1.1% -0.9% -2.0% -5.2% -8.2%
Return on Equity (ROE) 2.4% 0.6% -0.7% -0.8% -0.7% -1.6% -4.2% -5.7%
Return on Assets (ROA) 2.2% 0.5% -0.6% -0.7% -0.6% -1.4% -3.1% -4.8%
Current Ratio 11.30x 10.80x 4.03x 7.70x 7.93x 7.54x 4.54x 8.32x
Debt to Equity -- -- -- 0.00x 0.01x 0.01x 0.01x 0.01x
Revenue Growth (YoY) +19.0% +11.8% -7.1% -7.9% -18.8% +1.7% +3.8% -35.2%
Gross Profit Growth (YoY) +20.5% +10.2% -6.0% +3.1% -9.6% +32.4% +43.4% -21.9%
Net Income Growth (YoY) -- +144.3% +285.0% -100.6% -- -- -- --
Operating Cash Flow Growth (YoY) -74.3% -- -- +256.6% -- -- -159.2% -74.6%
Free Cash Flow Growth (YoY) -74.6% -- -- -- -- -- -159.2% -125.4%
Source: SEC EDGAR CompanyFacts (CIK 0001304161) · from July 31, 2010 Data through July 31, 2026 · synced Nov 21, 2026, 05:06 UTC · Open in terminal